Found 7 matching trials
Adaptive Immunotherapy for Nasopharyngeal Carcinoma
PHASE31. To assess whether radiotherapy alone is non-inferior to concurrent chemo...
Location
Sun Yat-sen University Cancer Center
Surgery Alone Verus Sugery Combined with Dose-reduced Radiotherapy for Newly Diagnosed Stage I Nasopharyngeal Carcinoma
NAThe goal of this clinical trial is to compare the efficacy and safety of en...
Location
The Fifth Affiliated Hospital of Guangzhou Medical University
Surgery Plus Target-reduction Chemoradiotherapy vs Regular Chemoradiotherapy for Newly Diagnosed Resectable Nasopharyngeal Carcinoma
NAThrough a prospective clinical trial, we intend to combine surgery, inducti...
Location
Sun Yat-sen University Cancer Center
Surgery Plus Reduced Target Chemoradiotherapy vs Surgery Plus Reduced Dose Chemoradiotherapy for Newly Diagnosed Operable Nasopharyngeal Carcinoma.
NAThe goal of this clinical trial is to compare surgery plus reduced target c...
Location
The Fifth Affiliated Hospital of Sun Yat-sen University
Endoscopic Nasopharyngectomy for Newly Diagnosed Stage I Nasopharyngeal Carcinoma Patients
NANasopharyngeal carcinoma (NPC) is most prevalent in eastern Asia, with the ...
Location
Sun Yat-sen University Cancer Center
A Randomized Controlled Clinical Trial of Surgery Versus Conservative Treatment for Mild and Moderate-grade Nasopharyngeal Necrosis
NAPost radiation nasopharyngeal necrosis is a relatively special radiotherapy...
Location
Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center
Induction Chemotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
PHASE21\. To see the effect if a combination of induction chemotherapy followed b...
Location
Sun Yat-sen University